Table 2.
Expression of MSC markers of ADHLSCs and comparison with BM-MSC and ASC.
Markers | ADHLSC | BM-MSC [14, 15] | ASC [15] |
---|---|---|---|
CD73 | 98.3% (95.0–99.7) | ≥95% (guideline) | ≥95% |
CD90 | 91.5% (86.9–95.0) | ≥95% (guideline) | ≥95% |
CD105 | 96.7% (93.8–99.6) | ≥95% (guideline) | ≥95% |
CD11b | 0.7% (0.0–2.0) | ≤2% (guideline) | ≤2% |
CD14 | 2.0% (0.0–3.26) | ≤2% (guideline) | ≤2% |
CD19 | 0.5% (0.0–2.0) | ≤2% (guideline) | ≤2% |
CD45 | 1.1% (0.0–2.8) | ≤2% (guideline) | ≤2% |
HLA-DR | 0.8% ± 0.5 | ≤2% (guideline) | ≤2% |
| |||
CD34 | 1.3% (0.1–2.6) | 0.1% (0.0−0.1) | 9.0% (5.1–30.1) |
CD36 | 3.5% (0.0–12.0) | 0.1% (0.0−0.2) | 11.5% (4.8–13.4) |
CD91 | 0.7% (0.0−1.7) | N.D. | 47.6% (12.7–87.4) |
CD140b | 93.8% (99.4–78.6) | 54.3% (45.9–87.5) | 79.9% (49.2–87.5) |
CD141 | 7.2% (4.2–12.8) | N.D. | ≥95% |
CD201 | 53.3% (0.17–81.1) | 2.0% (1.8–4.8) | 13.6% (9.5–25.6) |